Latent Labs

Latent Labs

Latent Labs is a frontier AI lab building generative models that capture the fundamentals of biology. Their platform provides AI-driven tools for de novo protein binder design, antibody engineering with low immunogenicity, and drug design agents. Targeting researchers and biotech partners, they offer models like Latent-X for atom-level protein design and Latent-Y as an agent for drug design, aiming to transform health and sustainability through programmable biology.

Search
Visit website
Added on
Sep 22, 2026
Protein designAntibody generationEnzyme optimizationGenerative biology AIResearcher tier
Product information

Everything worth knowing about Latent Labs

The complete picture — from everyday features to the technical detail builders and IT folks dig for.

Core features

What it actually does

Generative AI for Drug Design
Lab-validated agent (Latent-Y) for designing new drugs, providing control over molecular biology.
Antibody Optimization
Frontier models (Latent-X2) to generate drug-like antibodies with low immunogenicity in human panels.
De Novo Protein Binder Design
Atom-level frontier model (Latent-X) for creating novel protein binders from scratch.
Enzyme Optimization
Tools to optimize existing enzyme functions for specific applications.
Researcher Access Program
Latent-Y Research Tier offers free daily access and on-demand credits for larger campaigns to researchers worldwide.
Technical capabilities
Generative Models for Biology
Core technology is AI models trained to capture the fundamental principles of molecular biology.
Must watch videos
Why I couldn't build Jev at OpenAI — Diogo Almeida, TypeSafe Co-founder & CEO
2:22:22
Tutorial2:22:22
Why I couldn't build Jev at OpenAI — Diogo Almeida, TypeSafe Co-founder & CEO
From helping build instruction-following models at OpenAI to spending years trying to answer why AI can solve extraordinarily hard problems yet still automate so little real work, Diogo Almeida is betting that the next wave of AI won’t look like chat. In this episode, the TypeSafe founder and CEO joins swyx days after Jev’s breakout launch to explain System One Models: machine-native AI designed for code, calibrated decisions, reliability, and intelligence per dollar. We go deep on Jev and RLCD, the failure modes of RLHF, why TypeSafe refuses to optimize around public benchmarks, and why Diogo believes data and the right task matter more than simply scaling compute. Diogo also explains why he left OpenAI, why refusals and safety alignment become fundamentally different problems when AI is infrastructure, how Jev changes the architecture of coding agents, why AI should eventually disappear into the background of software, and why even with a billion dollars, he wouldn’t pre-train a model from scratch. We discuss: • Why AI can solve extraordinarily hard problems but still fail to automate basic work • What System One Models are and why Jev is built for software rather than chat • RLHF, mode collapse, calibration, and the hidden costs of optimizing for human preferences • Why refusals become a problem when AI is buried inside software dependencies • Why TypeSafe rejects public benchmarks and optimizes for intelligence per dollar • The “bitterest lesson”: why the right task and the right data can matter more than compute • Why TypeSafe thinks of itself as a data lab rather than a model lab • RLCD vs. RLHF and RLVR as fundamentally different North Stars for AI • Why reliability and robustness matter more than simple determinism • Jev’s programming primitives and how intelligence maps into software control flow • Why developers should decompose AI workflows into many small, measurable decisions • How structured state replaces giant prompts and system messages • Why Diogo thinks AI should eventually disappear into the background of software • The “inverse SaaS-pocalypse” and how AI could supercharge existing software • System One vs. System Two intelligence and the limits of reasoning models • Dark data, computer use, real-time intelligence, and Jev’s biggest early use cases • Why Jev could reshape coding agents built around a single-model architecture • Why Diogo says he wouldn’t pre-train even if you gave him a billion dollars • The OpenAI journey that led to TypeSafe and why he thinks most neo-labs are approaching AI incorrectly • Coding agents beyond the KV cache, shared state, sub-agents, and the future of multi-agent software — Diogo Almeida • LinkedIn: https://www.linkedin.com/in/diogomda/ • X: https://x.com/CompleteSkeptic Timestamps 00:00:00 Intro 00:01:29 Jev Launch Week and the AI Economic Revolution 00:04:19 What Is Jev? System One Models and Programmable AI 00:07:23 RLHF, Mode Collapse, Calibration, and Yann LeCun 00:11:58 Programmatic AI, Refusals, and Safety Alignment 00:18:50 Why TypeSafe Rejects Public Benchmarks 00:22:12 The Bitterest Lesson: Data, Compute, and the Right Task 00:26:28 RLCD vs. RLHF and RLVR 00:30:11 Why Powerful AI Still Hasn’t Automated the Economy 00:41:24 Reliability, Robustness, and Determinism 00:49:40 Model Versioning, LTS, Speed, and Intelligence per Dollar 00:55:33 Inside Jev’s API and Programming Primitives 00:59:57 How to Build with Jev: Structure, Decomposition, and Small Decisions 01:19:57 The Inverse SaaS-pocalypse and AI Disappearing into Software 01:34:50 Computer Use, Dark Data, and Jev’s Biggest Use Cases 01:40:17 How Jev Could Reshape Coding Agents 01:42:29 AI Safety, Frontier Pacing, and the Limits of RLVR 01:49:32 Why Diogo Wouldn’t Pre-Train with $1 Billion 01:56:48 The OpenAI Story Behind TypeSafe 02:03:10 Why Diogo Thinks Most Neo-Labs Are Getting AI Wrong 02:09:29 Coding Agents Beyond the KV Cache and the Multi-Agent Future
AWS Founder Spotlight: Latent Labs | Amazon Web Services
2:00
Tutorial2:00
AWS Founder Spotlight: Latent Labs | Amazon Web Services
In Julien Offray de La Mettrie’s 18th century work, l’homme machine, the philosopher likened the human body to a complex machine. Decades later, pioneering biologists and biophysicists like Thomas Huxley and Francis Crick drew comparable analogies. Today, that mechanistic view of biology shapes the operations, mission, and future ambitions ofLatent Labs. “Biology underpins humanity; all of our bodies are made up of its building blocks,” says Simon Kohl, founder and CEO. This field of science, he explains, is “a system that computes,” and our cells, like “mini-computers.” Latent Labs engaged with AWS through theAWS Generative AI Accelerator Program, accessing support, connections to the AWS network, go-to-market strategies, and solutions includingAmazon SageMaker HyperPod. This has enabled the company to train and build proprietary models and efficiently and reliably scale compute and inference resources. In doing so, it’s “breaking conventions of the past” with a generative-AI powered approach to protein design that “sidesteps and augments lab experiments.” Learn more about how to grow your startup with AWS: https://go.aws/44vhvjl Subscribe to AWS: https://go.aws/subscribe Sign up for AWS: https://go.aws/signup AWS free tier: https://go.aws/free Explore more: https://go.aws/more Contact AWS: https://go.aws/contact Next steps: Explore on AWS in Analyst Research: https://go.aws/reports Discover, deploy, and manage software that runs on AWS: https://go.aws/marketplace Join the AWS Partner Network: https://go.aws/partners Learn more on how Amazon builds and operates software: https://go.aws/library Do you have technical AWS questions? Ask the community of experts on AWS re:Post: https://go.aws/3lPaoPb Why AWS? Amazon Web Services (AWS) is the world’s most comprehensive and broadly adopted cloud. Millions of customers—including the fastest-growing startups, largest enterprises, and leading government agencies—use AWS to be more agile, lower costs, and innovate faster. #AI #generativeAI #Startup #AWS #AmazonWebServices #CloudComputing
Best MiniMax H3 Long Video Latent Context Workflow — No Degradation
15:06
Tutorial15:06
Best MiniMax H3 Long Video Latent Context Workflow — No Degradation
📦 FREE RESOURCE PACK https://promptmastery4.gumroad.com/l/ywlmso ☁️ RUN IT ON AN RTX 4090 IN THE CLOUD — FREE Register with the link below, try the workflow, and get 1,100 free coins to start. MINIMAX H3 Motion Context V2 https://www.runninghub.ai/post/2102239919971270657/?inviteCode=rh-v1580 🆕 First time on RunningHub? Watch this first: https://www.youtube.com/watch?v=WD6roXe7r60 💬 Any questions, come and ask in the community: https://discord.gg/BpM2c7TWTv Chain MiniMax H3 clips into one continuous long take, 45 seconds and beyond, with no visible join between segments. The trick is single-pass sampling: upscale the chain and the pixels shift at every seam. This is Motion Context V2, a long-video workflow for MiniMax H3 in ComfyUI. Each new segment picks up the last frames of the one before it, picture and sound, so the motion, the voice and the scene carry straight through. The pirate ship shots at the start are three 15-second segments each, at 1.2 megapixels. In the video: - The model stack: Singularity Ref2VA v1.3 with the turbo 4-step v0.1 LoRA (they have to be paired) - Why 8 steps: the picture holds up over a long chain, the audio doesn't at lower step counts - The Multi-Track Editor: segments, timing, reference-to-video mode, match vs max - Shot vs context, and how one shared reference image carries through every segment - Writing prompts that link, with an LLM system prompt that plans the segments and writes them for you - Why it has to be single pass: latent upscale or a second sampling stage both shift pixels at the joins - Segment start and count, then the render The one gotcha: segment_start_number counts from 1, and on a cloud run the whole chain renders together, so you can't redo just one segment there. Locally the latents are saved and you can. Start small. Try 0.5 megapixels and 5 to 8 second segments before you go for 15. ⏱️ CHAPTERS 0:00 The result: 45-second seamless long takes 1:25 Long video with Motion Context 2:06 Model: Singularity 1.3 + 4-step LoRA 3:52 Why 8 steps (the audio degrades) 4:27 Multi-Track Editor + reference-to-video mode 6:22 Shot vs context: how segments link 7:36 One shared reference image 8:31 Writing prompts that link 11:47 Why single pass: upscaling shifts pixels 13:31 Final result + tips for your first long take 🔗 LINKS Channel memberships: https://www.youtube.com/channel/UCYaPATFpSxsvTqObBKoW3_Q/join All resource packs: https://promptmastery4.gumroad.com #minimaxh3 #comfyui #aivideo #runninghub

Who uses it

Real use cases, no hype
Antibody Design
Generate novel antibody sequences with desired binding properties and low immunogenicity.
Enzyme Optimization
Improve the stability, activity, or specificity of existing enzymes for industrial or therapeutic use.
De Novo Protein Creation
Design entirely new proteins from scratch to bind specific molecular targets.
Drug-Like Molecule Generation
Create candidate molecules with optimized pharmacokinetic properties for drug development.
Genetic Engineering
Program biological systems by designing precise protein-DNA interactions.
Research Acceleration
Rapidly prototype and validate biological hypotheses using AI-generated designs.
Sustainability Biotech
Engineer proteins for processes like carbon capture, biodegradable plastics, or biofuel production.
What's great
  • Pioneering AI models for protein design and drug discovery.
  • Lab-validated results for tangible biological outcomes.
  • Founded by former DeepMind team behind AlphaFold.
  • Free daily access tier for researchers.
Technical strengths
  • Offers specialized models (Latent-X1, X2, Y) for distinct tasks.
  • Atom-level frontier model for de novo protein binder design.
  • Models optimized for low immunogenicity in human panels.
Where it falls short
  • Highly specialized; not for general-purpose coding or business apps.
  • Access is gated through a research platform; no open-source.
  • Target audience is narrow: computational biologists and pharma R&D.
Technical limitations
  • Documentation is likely sparse or non-existent for external developers.
  • API and integration specifics are not publicly detailed.
  • Pricing for on-demand credits is not transparent on the homepage.
For technical folks

The deep-dive specs

FAQ

Includes technical Q&A
They specialize in proteins: antibodies, enzymes, de novo protein binders, and drug-like molecules derived from biological scaffolds.

Traffic Insights

Monthly Visits

—

October 2026

Growth Rate

0%

vs last month

Dominance

0%

in Search

Top Country

—

Top Countries Breakdown

—

Growth Trend

Stable

Traffic has remained stable.

Pricing overview
Freemium Pricing

Latent Labs Pricing

Latent Labs uses a freemium pricing structure. Real-time rates, custom enterprise quotas, and plan details are managed directly on their official platform.

Check Pricing on Latent Labs
Reviews

What the internet actually thinks

Data refreshed weekly. No paid placements.

Trustpilot
Not reviewed yet
G2
G2
Not reviewed yet
C
Capterra
Not reviewed yet
Product Hunt
Not reviewed yet
COMMUNITY COMMENTS

Leave a Comment

Help others make informed decisions. Your honest feedback shapes the community's understanding of this tool.

Tips for commenting

  • •Be specific about features you used
  • •Share real use cases and results
  • •Mention both pros and cons
  • •Keep it honest and constructive
to leave a comment

Your comment is published immediately.

Filter:
Sort:

No comments yet

Be the first to share your experience with this tool.

Alternatives

Not quite the right fit?

Here's what else is out there.